ASCENTAGE PHARMA GROUP INTERNATIONAL

Annual Trend FY 2012 FY 2013 FY 2014 FY 2015 FY 2016 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Net Income ($155k)
($782k) -404.88%
($283k) +63.84%
($1.5m) -440.93%
($882.9m)
($925.6m) -4.84%
($405.4m) +56.20%
($1.2b) -206.53%
($1.2b) +0.54%
Net Income From Continuing Operations ($887.2m) ($932.9m) ($395.3m) ($1.2b) ($1.2b)
Net loss ($100k) ($169k) ($184k) ($283k)
Profit or Loss ($925.7m) ($55.6m)
Depreciation of property, plant and equipment $38.2m $55.3m $71.2m $65.8m $86.5m
Depreciation of investment property $1.4m $15.9m $86.5m
Depreciation of right-of-use assets $13.5m $11.6m $11.1m $10.7m $86.5m
Amortization of intangible assets $9.8m $10.4m $10.9m $10.1m
Depreciation Expense $572 $285 $86.5m
Amortization Cash Flow $9.8m $10.4m $10.9m $10.1m
Amortization Of Intangibles $3k $9.8m $10.4m $10.9m $10.1m $10.1m
Depreciation $53.1m $82.8m $82.3m $76.4m $76.4m
Depreciation Amortization Depletion $62.9m $93.2m $93.2m $86.5m $86.5m
Adjustments For Share-Based Payments $31.5m $2.9m
Equity-settled share-based payments $22.1m $31.5m $20.9m $20.9m
Stock-Based Compensation Expense $7k $0 $20.9m
Stock-Based Compensation (Equity) $32k $7k $20.9m
Impairment of Good2Drive ($9k) $155k
Impairment of mineral rights $0 $13k
Asset Impairment Charge $0 $0 $4.2m $4.2m
Earnings (Loss)es From Equity Investments $278k ($1.1m) $281k ($314k) ($314k)
Change In Working Capital $6k $105k $94k ($4k) $104.4m ($9.1m) $111.0m ($143.5m) ($143.5m)
(Increase)/Decrease in trade receivables ($388k) ($91.5m) $62.8m ($169.8m)
Increase in prepayments, other receivables and other assets $3.1m ($7.8m) ($14.4m) ($86.3m)
Change In Receivables ($388k) ($91.5m) $62.8m ($169.8m) ($169.8m)
Changes In Account Receivables ($388k) ($91.5m) $62.8m ($169.8m) ($169.8m)
(Increase)/Decrease in inventories ($5.5m) ($6.7m) $9.6m ($26.2m) ($26.2m)
Change In Inventory ($5.5m) ($6.7m) $9.6m ($26.2m) ($26.2m)
(Decrease) /Increase in trade payables $24.7m ($23.1m) $19.5m $14.8m
Increase in other payables and accruals $57.4m $48.6m $78.5m $113.8m
Increase in accounts payable $2k $21k $30k $154k $277k
Change in Accounts Payable $7k $58k
Accrued interest $11k $20k $28k ($31k)
Change In Other Current Assets $29.4m ($3.6m) ($49.0m) $27.8m $27.8m
Change In Other Current Liabilities ($10.1m) $0
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $2.4m $14k $50k $18k
Purchases of property, plant and equipment ($203.3m) ($46.1m) ($24.3m) ($27.6m)
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates $1.1m ($38k)
Net cash flows generated from/ (used in) investing activities ($384.6m) $21.9m ($362.0m) ($1.0b)
Net Cash from Investing Activities ($6k) $0 ($9k) $168k
Proceeds From Borrowings Classified As Financing Activities $953.5m $73.4m
Repayments Of Borrowings Classified As Financing Activities $956.1m $92.2m
Proceeds from Debt Issuance $50k $29k $2k $75k
Issuance Of Debt $763.6m $953.5m $535.9m $1.2b $1.2b
Long Term Debt Issuance $763.6m $953.5m $535.9m $1.2b $1.2b
Net Issuance Payments Of Debt $695.9m ($13.4m) ($145.3m) $307.3m $307.3m
Net Long Term Debt Issuance $695.9m ($13.4m) ($145.3m) $307.3m $307.3m
Long Term Debt Payments ($67.7m) ($966.9m) ($681.3m) ($933.7m) ($933.7m)
Repayment Of Debt ($67.7m) ($966.9m) ($681.3m) ($933.7m) ($933.7m)
Issuance Of Capital Stock $0 $470.1m $533.9m $2.3b $2.3b
Repurchase Of Capital Stock ($26.8m) ($5.9m) $0 ($9.0m) ($9.0m)
Common Stock Issuance $0 $470.1m $533.9m $2.3b $2.3b
Net Common Stock Issuance ($26.8m) $464.2m $533.9m $2.3b $2.3b
Common Stock Payments ($26.8m) ($5.9m) $0 ($9.0m) ($9.0m)
Cash Dividends Paid $0 $0 $0 $0 $0
Net Other Financing Charges ($16.1m) $10.3m ($13.3m) ($11.7m) ($11.7m)
Net cash flows generated from financing activities $619.3m
$368.8m -40.45%
$314.8m -14.64%
$2.5b +706.98%
Net Cash from Financing Activities $5k
$18k +258.00%
$2k -86.03%
$75k +2887.36%
($100k) -234.00%
(Increase)/ Decrease in restricted cash balances $20.3m ($7.9m) ($96k) $18.9m
NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS ($419.3m) ($335.4m) ($158.6m) $365.9m
Cash - Beginning of Year $2k $2k
Cash, beginning of period $2k $6k $6k $2k $8k
Beginning Cash Position $1.7b $1.3b $1.0b $893.1m $893.1m
Cash and cash equivalents at beginning of year $1.7b $1.3b $1.0b $893.1m $1.2b $893.1m
Effect of foreign exchange rate changes, net $58.0m $27.8m $13.7m ($63.2m)
Effect Of Exchange Rate Changes $58.0m $27.8m $13.7m ($63.2m) ($63.2m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Interest Expense $0 $0 $0
Additional Financial Items
Adjustments For Decrease Increase In Trade Account Receivable $24.7m ($91.5m) $8.6m $14.8m
Adjustments For Finance Costs $96.1m $8.8m
Adjustments For Unrealised Foreign Exchange Losses Gains ($1.6m) ($917k)
Goodwill $24.7m $3.4m $4.2m
Payments Of Lease Liabilities Classified As Financing Activities $10.8m $1.2m
Payments To Acquire Or Redeem Entitys Shares $5.9m
Proceeds From Issuing Shares $470.1m $73.1m
Purchase Of Intangible Assets Classified As Investing Activities $6k $33.7m $10.7m
Loss before tax ($887.2m) ($932.9m) ($395.3m) ($1.2b)
Gain on disposal of leases ($205k) ($85k) ($685k)
Fair value loss on financial assets measured at FVTPL $9.8m $699k $832k $1.1m
Fair value loss on financial liabilities measured at FVTPL ($19.4m) ($2.8m) $29.5m
Finance costs $52.8m $96.1m $64.5m $54.1m
Share of (profit)/loss of a joint venture $278k ($1.1m) $281k ($314k)
Foreign exchange (gain)/loss $2.7m ($1.6m) ($6.7m) $10.2m
Total ($758.3m) ($716.9m) ($222.3m) ($1.0b)
(Increase) /Decrease in other non-current assets $29.4m ($3.6m) ($49.0m) $27.8m
Increase /(Decrease) in contract liabilities ($24.4m) $81.6m ($3.7m) ($37.5m)
Increase in deferred income ($300k) $1.4m $7.7m $1.0m
Purchase of intangible assets ($6k) ($33.7m) ($10.7m)
Payment of contingent consideration related to acquisition of a subsidiary ($20.0m) ($20.0m) ($9.5m) ($43.3m)
Maturity/(Placement) in time deposits with original maturity of more than three months ($130.0m) $98.8m ($312.2m) ($925.1m)
Proceeds from issue of shares $470.1m $533.9m $2.3b
Treasury share purchases ($26.8m) ($5.9m) ($9.0m)
Proceeds from exercise of share options $19k $8k $6k $4k
Proceeds from bank loans $763.6m $953.5m $535.9m $1.2b
Repayment of bank loans ($54.5m) ($956.1m) ($672.9m) ($924.0m)
Principal portion of lease payments ($13.2m) ($10.8m) ($8.4m) ($9.7m)
Listing expense paid ($13.3m) ($11.7m)
Restricted bank balances $16.6m $24.5m $24.6m $5.7m
Time deposits with original maturity of more than three months $130.0m $31.2m $343.5m $1.3b
Cash and bank balances at end of year $1.5b $1.1b $1.3b $2.5b
Change in Other Working Capital $6k $105k $94k ($4k) ($4.3m) $75.0m $4.0m ($17.5m) ($17.5m)
Stock Repurchases (Issuances) $15k $0 $0 $0
Net Change in Cash $231 $14k ($5k) $7k $9k
Prepaid deposits $6k ($4k) ($4k)
Proceeds from loans - related party $30k $0 $9k $0
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES $85k $22k $2k $116k $730k
Proceeds from stock issued for services $0 $487k
Increase in payable to related parties $0 ($80k)
Proceeds of stock $32k $830k
Foreign Currency Translation $0 ($2k) ($6k)
Income taxes $0 $0 $0
Purchase of Good2Drive LLC $0 $155k $0
Purchase of mineral rights $0 ($9k)
Cash Flow From Continuing Financing Activities $619.3m $368.8m $314.8m $2.5b $2.5b
Cash Flow From Continuing Investing Activities ($384.6m) $21.9m ($362.0m) ($1.0b) ($1.0b)
Change In Account Payable $24.7m ($23.1m) $19.5m $14.8m $14.8m
Change In Payable $82.1m $25.5m $98.0m $128.6m $14.8m
Change In Prepaid Assets $3.1m ($7.8m) ($14.4m) ($86.3m) ($86.3m)
Changes In Cash ($419.3m) ($335.4m) ($158.6m) $365.9m $365.9m
End Cash Position $1.3b $1.0b $893.1m $1.2b $1.2b
Financing Cash Flow $619.3m
$368.8m -40.45%
$314.8m -14.64%
$2.5b +706.98%
$2.5b 0.00%
Free Cash Flow ($890.9m) ($782.9m) ($135.6m) ($1.2b) ($1.2b)
Gain Loss On Investment Securities ($87.6m) ($19.4m) ($2.8m)
Gain Loss On Sale Of PPE ($2.1m) ($4k) $50k $18k $18k
Investing Cash Flow ($384.6m) $21.9m ($362.0m) ($1.0b) ($1.0b)
Net Business Purchase And Sale ($20.0m) ($20.0m) ($25.5m) ($43.3m) ($43.3m)
Net Foreign Currency Exchange Gain Loss $2.7m ($1.6m) ($6.7m) $10.2m $10.2m
Net Intangibles Purchase And Sale ($33.7m) ($10.7m) $0 $0 $0
Net PPE Purchase And Sale ($200.9m) ($46.1m) ($24.3m) ($27.6m) ($27.6m)
Operating Gains Losses ($18.5m) ($5.5m) ($6.4m) $9.9m $9.9m
Other Non Cash Items $52.6m $96.1m $64.4m $82.9m
Proceeds From Stock Option Exercised $19k $8k $6k $4k $4k
Purchase Of Business ($20.0m) ($20.0m) ($25.5m) ($43.3m) ($43.3m)
Purchase Of Intangibles ($33.7m) ($10.7m) $0 $0 $0
Purchase Of PPE ($203.3m) ($46.1m) ($24.3m) ($27.6m) ($27.6m)
Sale Of PPE $2.4m $14k $0 $0 $0
Stock Based Compensation $22.1m $31.5m $20.9m $20.9m $20.9m
Unrealized Gain Loss On Investment Securities $9.8m $699k $832k $1.1m $1.1m
Net Investment Purchase And Sale ($130.0m) $98.8m ($312.2m) ($929.1m) ($929.1m)
Purchase Of Investment ($130.0m) $0 ($312.2m) ($929.1m) ($929.1m)
Sale Of Investment $1.8b $0 $98.8m
Change In Cash Supplemental As Reported ($419.3m) ($335.4m) ($158.6m) $365.9m
Interest Paid Classified As Financing Activities ($49.8m) $92.3m $8.3m ($51.3m)
Income tax paid $0 $0 $0 ($29k)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.